관절경 검사 기구 시장 기회와 촉진요인, 업계 동향 분석 및 예측(2025-2034년)

The Global Arthroscopy Instruments Market was valued at USD 6.5 billion in 2024 and is estimated to grow at a CAGR of 3.9% to reach USD 9.4 billion by 2034. Rising rates of joint-related conditions, a growing elderly population, and increasing sports injuries are among the major forces driving this market. There is a growing shift toward minimally invasive procedures, and arthroscopy stands out as a preferred approach due to its benefits, such as shorter recovery times, reduced hospital stays, and lower post-operative complications. Additionally, advancements in visualization technologies, robotics integration, and a greater emphasis on disposable devices are transforming arthroscopy procedures. Increasing patient awareness about early treatment and diagnosis of joint issues is also helping to fuel demand for these instruments globally.

Ambulatory surgical centers, especially in urban settings, are rapidly expanding and becoming major hubs for outpatient arthroscopy, contributing further to market growth. Expanding healthcare infrastructure in emerging economies, alongside rising expenditure, is encouraging broader adoption of arthroscopic techniques and devices across both public and private health sectors.

The powered shaver systems captured a 23.9% share in 2024, owing to their essential role in delivering precise tissue and bone resection during minimally invasive joint procedures. Their superior efficiency, ease of handling, and ability to integrate seamlessly with advanced visualization systems make them a preferred tool in modern arthroscopic surgeries. Their growing use in outpatient surgical centers is helping fuel adoption, as they reduce operation time while enhancing precision and procedural success.

The knee arthroscopy segment held the largest market share at 41.6% in 2024, attributed to the high volume of knee-related injuries and osteoarthritis cases globally. The segment benefits from growing sports participation, a rise in elderly populations, and a broader shift toward minimally invasive interventions. Ligament tears and cartilage damage are routinely addressed using arthroscopic methods, making it the most performed procedure. Improvements in techniques, tools, and recovery outcomes continue to support its dominance across both developed and developing regions.

North America Arthroscopy Instruments Market held a 35.3% share in 2024. This leadership is driven by advanced surgical infrastructure, early adoption of cutting-edge medical technologies, and a high frequency of orthopedic procedures. The U.S. and Canada continue to invest in specialty orthopedic centers and outpatient surgical facilities, enabling wide-scale integration of minimally invasive techniques. Rising life expectancy, combined with the increasing prevalence of osteoarthritis and sports injuries, further accelerates the demand for arthroscopic tools across the region.

Key participants in the Global Arthroscopy Instruments Market include Olympus, Medacta, Smith & Nephew, Medtronic, Hemodia, Stryker, Richard Wolf, CONMED, Karl Storz, Arthrex, Invamed, Zimmer Biomet, B. Braun, and DePuy Synthes (J&J). Leading companies in the arthroscopy instruments market are advancing their position through consistent investment in next-generation surgical technologies. Innovations in robotics, AI-driven visualization, and disposable tools are helping these firms offer greater precision, shorter recovery periods, and enhanced clinical outcomes. Several players are expanding their outpatient-specific product lines to meet rising demand from ambulatory surgical centers. Strategic collaborations with healthcare institutions and sports medicine specialists are enabling companies to develop procedure-specific instruments tailored to evolving surgical techniques. Additionally, many are targeting high-growth emerging markets by strengthening regional distribution networks and launching cost-effective instrument lines.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product type trends
  • 2.2.3 Application trends
  • 2.2.4 Usability trends
  • 2.2.5 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of sports-related injuries and orthopedic disorders
    • 3.2.1.2 Growing demand for minimally invasive surgical procedures
    • 3.2.1.3 Increasing geriatric population prone to joint diseases
    • 3.2.1.4 Advancements in arthroscopic visualization and imaging technologies
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of arthroscopy equipment and implants
    • 3.2.2.2 Limited accessibility in low-income and rural regions
  • 3.2.3 Market opportunities
    • 3.2.3.1 Technological integration with AI and robotic-assisted arthroscopy
    • 3.2.3.2 Growth potential in emerging markets
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Supply chain analysis
• 3.7 Consumer behaviour trend
• 3.8 Go-to-market strategy analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis
• 3.11 Future market trends
• 3.12 Gap analysis
• 3.13 Pricing analysis, 2024
• 3.14 Patent Landscape
• 3.15 Reimbursement scenario
  • 3.15.1 Impact of reimbursement policies on market growth

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 Global
  • 4.2.2 North America
  • 4.2.3 Europe
  • 4.2.4 Asia Pacific
  • 4.2.5 Latin America
  • 4.2.6 Middle East and Africa
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Powered shaver systems
• 5.3 Visualization systems
• 5.4 Arthroscopes
• 5.5 Fluid management systems
• 5.6 Arthroscopic implants
• 5.7 Radiofrequency (RF) ablation systems
• 5.8 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Knee arthroscopy
• 6.3 Shoulder arthroscopy
• 6.4 Hip arthroscopy
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By Usability, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Reusable arthroscope
• 7.3 Disposable arthroscopes

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Arthrex
• 10.2 B. Braun
• 10.3 CONMED
• 10.4 DePuy Synthes (J&J)
• 10.5 Hemodia
• 10.6 Invamed
• 10.7 Karl Storz
• 10.8 Medacta
• 10.9 Medtronic
• 10.10 Olympus
• 10.11 Richard Wolf
• 10.12 Smith & Nephew
• 10.13 Stryker
• 10.14 Zimmer Biomet